secwatch.observer — SEC 8-K summary
======================================

Issuer:     SeaStar Medical Holding Corp (ICU)
CIK:        0001831868
Form:       8-K
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001193125-23-086140
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SeaStar Medical reports 2022 net loss of $23.0M; cash only $47K
---------------------------------------------------------------

- Net loss $23.0M ($2.80/share) vs $4.6M ($0.63/share) in 2021; G&A expenses rose to $6.6M from $1.7M.
- Cash at Dec 31, 2022 was $47,000, down from $510,000; company raised $3.3M in March 2023 convertible debt.
- SCD device for adult AKI: NEUTRALIZE-AKI trial to enroll up to 200 patients; expects FDA PMA filing in Q3 2024.
- Pediatric AKI HDE application under FDA review; license/distribution agreement with Nuwellis for top 50 U.S. hospitals.
- R&D expenses flat at $2.8M; other expense surged to $11.4M from $0.2M, driven by $10.2M loss on forward option.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831868/000119312523086140/0001193125-23-086140-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831868/000119312523086140/d492852d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-086140

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer